Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 2125.HK
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 0.00 2.99 2.99
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -2.32 -2.56 -2.50
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 0.00 2.56 2.56
Cash -5.05 0.24 0.26
Capex 0.00 < 0.005 < 0.005
Free Cash Flow 0.00 < 0.005 < 0.005
Revenue 0.00 0.28 0.28
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 0.00 -0.05 -0.05
Operating Margin 0.00 -0.33 -0.33
ROA 0.00 -0.02 -0.02
ROE 0.00 -0.03 -0.03
ROIC 0.18 -0.03 -0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 2125.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 2125.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 2125.HK is permitted for members.